Arax Advisory Partners’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-841
Closed -$2K 758
2020
Q3
$2K Hold
841
﹤0.01% 650
2020
Q2
$3K Hold
841
﹤0.01% 621
2020
Q1
$2K Hold
841
﹤0.01% 636
2019
Q4
$3K Hold
841
﹤0.01% 541
2019
Q3
$5K Hold
841
﹤0.01% 519
2019
Q2
$5K Buy
+841
New +$4.93K ﹤0.01% 520
2018
Q4
$6K Hold
841
﹤0.01% 479
2018
Q3
$7K Buy
+841
New +$6.09K ﹤0.01% 502

Other funds holding SRTS

Arax Advisory Partners's SRTS Position: Q4 2020 in Review

Arax Advisory Partners sold out of Sensus Healthcare (SRTS) in Q4 2020, closing a stake of 841 shares — an estimated $2K sold.

Arax Advisory Partners first reported a position in SRTS in Q3 2018 and held it in 8 quarters. The position peaked at $7K in Q3 2018. 18 funds tracked by Wall St. Rank hold SRTS as of Q4 2020.

  • Arax Advisory Partners reported no remaining Sensus Healthcare position as of Q4 2020 after selling out during the quarter.
  • Arax Advisory Partners sold 841 Sensus Healthcare shares in Q4 2020, an estimated $2K.
  • Arax Advisory Partners first reported a position in Sensus Healthcare in Q3 2018 and held it in 8 quarters.
  • Arax Advisory Partners's Sensus Healthcare position peaked at $7K in Q3 2018.
  • 18 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2020.

Based on Arax Advisory Partners's 13F filing for Q4 2020, filed 3 Feb 2021.